Cargando…
An attenuated Lassa vaccine in SIV-infected rhesus macaques does not persist or cause arenavirus disease but does elicit Lassa virus-specific immunity
BACKGROUND: Lassa hemorrhagic fever (LHF) is a rodent-borne viral disease that can be fatal for human beings. In this study, an attenuated Lassa vaccine candidate, ML29, was tested in SIV-infected rhesus macaques for its ability to elicit immune responses without instigating signs pathognomonic for...
Autores principales: | Zapata, Juan C, Poonia, Bhawna, Bryant, Joseph, Davis, Harry, Ateh, Eugene, George, Lanea, Crasta, Oswald, Zhang, Yan, Slezak, Tom, Jaing, Crystal, Pauza, C David, Goicochea, Marco, Moshkoff, Dmitry, Lukashevich, Igor S, Salvato, Maria S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3602176/ https://www.ncbi.nlm.nih.gov/pubmed/23402317 http://dx.doi.org/10.1186/1743-422X-10-52 |
Ejemplares similares
-
Transcriptome Analysis of Human Peripheral Blood Mononuclear Cells Exposed to Lassa Virus and to the Attenuated Mopeia/Lassa Reassortant 29 (ML29), a Vaccine Candidate
por: Zapata, Juan Carlos, et al.
Publicado: (2013) -
Role of the Fas/FasL pathway in HIV or SIV disease
por: Poonia, Bhawna, et al.
Publicado: (2009) -
Advanced Vaccine Candidates for Lassa Fever
por: Lukashevich, Igor S.
Publicado: (2012) -
A potent Lassa virus antiviral targets an arenavirus virulence determinant
por: Madu, Ikenna G., et al.
Publicado: (2018) -
Gene expression patterns in human blood cells exposed to common flu-like viruses and arenavirus
por: Zapata, JC, et al.
Publicado: (2006)